Intervention Protocol

Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal women

  1. Christoph G Mosch*,
  2. Thomas Jaschinski,
  3. Michaela Eikermann

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 14 JUL 2014

DOI: 10.1002/14651858.CD011210


How to Cite

Mosch CG, Jaschinski T, Eikermann M. Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal women (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD011210. DOI: 10.1002/14651858.CD011210.

Author Information

  1. University Witten/Herdecke, Institute for Research in Operative Medicine (IFOM) - Department for Evidence-based Health Services Research, Cologne, Germany

*Christoph G Mosch, Institute for Research in Operative Medicine (IFOM) - Department for Evidence-based Health Services Research, University Witten/Herdecke, Cologne, Germany. christoph.mosch@uni-wh.de.

Publication History

  1. Publication Status: New
  2. Published Online: 14 JUL 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The purpose of this systematic review is to identify and summarise the results of randomised controlled trials that assess the benefits and harms of transvaginal sonography or other screening measures (e.g. serum CA-125 or HE4) and multimodal testing, for ovarian cancer screening in asymptomatic postmenopausal women with an average EOC risk by evaluating the screening-related patient-relevant outcomes (e.g. EOC-specific mortality rates).